Blockade of Inflammation and Apoptosis Pathways by Sirna Prolongs Cold Preservation Time and Protects Donor Hearts in a Porcine Model
Jia Wei,Shiyou Chen,Song Xue,Qiangru Zhu,Sha Liu,Li Cui,Xiuguo Hua,Yongyi Wang
DOI: https://doi.org/10.1016/j.omtn.2017.10.020
IF: 10.183
2017-01-01
Molecular Therapy — Nucleic Acids
Abstract:In donor hearts from mini pigs, overtime cold preservation and ischemia-reperfusion injury cause poor graft quality and impaired heart function. Blockage of complement, apoptosis, and inflammation is considered a strategy for attenuating ischemia-reperfusion injury and protecting cardiac function. Minipig donor hearts were perfused and preserved in Celsior solution or transfection reagent containing Celsior solution with scramble siRNA or siRNAs targeting complement 3, caspase-8, caspase-3, and nuclear factor kB-p65 genes at 4 degrees C and subsequently hemo-reperfused ex vivo (38 degrees C) or transplanted into recipients. The protective effect of the siRNA solution was evaluated by measuring cell apoptosis, structural alteration, protein markers for tissue damage and oxidative stress, and cardiac function. We found a reduction in cell apoptosis, myocardial damage, and tissue inflammation by reduced biochemistry and markers and protein expression of proinflammatory cytokines and improvement in cardiac function, as shown by the improved hemodynamic indices in 12-hrpreserved siRNA-treated hearts of both ex vivo and orthotopic transplantation models. These findings demonstrate that blockade of inflammation and apoptosis pathways using siRNA can prolong cold preservation time and better protect donor heart function in cardiac transplantation of large animals, which may be beneficial for human heart preservation.